Document Detail

Effects of methylprednisolone on acute lung paraquat toxicity in sheep.
MedLine Citation:
PMID:  3122611     Owner:  NLM     Status:  MEDLINE    
Infused into sheep, paraquat causes increased flow of protein-rich lung lymph, increased prostanoid production, and neutrophil accumulation in the lung. The effects of high-dose methylprednisolone on the response to paraquat infusion were studied in awake sheep with chronic lung lymph fistulas. Seven sheep were infused with paraquat (30 mg/kg) alone. Six sheep received methylprednisolone (1.0 g plus 0.5 g/h intravenously), beginning 30 min before paraquat (pretreatment), and 5 received methylprednisolone, beginning 4 h after paraquat (post-treatment). Neutrophil accumulation in the lung was measured in biopsy tissue taken at baseline and at postmortem. Methylprednisolone pretreatment significantly prevented the increase in lung lymph flow (paraquat, from 4.4 +/- 0.3 to 11.1 +/- 0.8 ml/h, p less than 0.05; pretreatment, from 4.8 +/- 0.9 to 3.7 +/- 0.3, NS), and the increase in lymph-to-plasma protein concentration ratio (paraquat, from 0.69 +/- 0.02 to 0.80 +/- 0.02, p less than 0.05; pretreatment, from 0.66 +/- 0.06 to 0.60 +/- 0.02, NS) during 8 h after paraquat infusion. Treatment with methylprednisolone after paraquat also reduced the changes in lung lymph flow and protein clearance. Methylprednisolone prior to paraquat significantly inhibited accumulation of 6-keto-PGF1 alpha in lymph and plasma, but did not significantly inhibit accumulation of TxB2 in lymph or plasma. The number of neutrophils in the paraquat lungs was 3 to 4 times that in the control lungs, with or without methylprednisolone. Methylprednisolone pretreatment prolonged the survival time, but did not prevent death within 48 h after paraquat infusion.(ABSTRACT TRUNCATED AT 250 WORDS)
K Kitazawa; T Kobayashi; T Shibamoto; K Hirai
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American review of respiratory disease     Volume:  137     ISSN:  0003-0805     ISO Abbreviation:  Am. Rev. Respir. Dis.     Publication Date:  1988 Jan 
Date Detail:
Created Date:  1988-02-10     Completed Date:  1988-02-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370523     Medline TA:  Am Rev Respir Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  173-80     Citation Subset:  AIM; IM    
First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
6-Ketoprostaglandin F1 alpha / blood
Acute Disease
Carbon Dioxide / blood
Hemodynamics / drug effects
Leukocyte Count
Lung / drug effects*,  metabolism,  pathology
Lymph / drug effects,  metabolism,  physiology
Methylprednisolone / pharmacology*
Oxygen / blood
Paraquat / toxicity*
Proteins / metabolism
Thromboxane B2 / blood
Reg. No./Substance:
0/Proteins; 124-38-9/Carbon Dioxide; 4685-14-7/Paraquat; 54397-85-2/Thromboxane B2; 58962-34-8/6-Ketoprostaglandin F1 alpha; 7782-44-7/Oxygen; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of a third sequential tuberculin skin test in a chronic care population.
Next Document:  Hydrogen-peroxide-induced arachidonic acid metabolism in the rat alveolar macrophage.